David Abrams recent buys & sells (2017 Q4)
Abrams Capital Management
Abrams Capital Management Portfolio Changes
Purchase & sale details
- Portfolio value:
- $2.97B (+$408M)
- Previous value:
- $2.56B
- # of changes:
- 11
- New positions:
- 2
- Reported for:
- 31 Dec 2017 (Q4)
- Latest filing date:
- 13 Feb 2018
Abrams Capital Management has disclosed a total of 11 changes to the portfolio in the (2017 Q4) SEC report(s): increased the number of shares of 5, bought 2 totally new and decreased the number of shares of 4 position(s).
What stocks did David Abrams buy in 2017 Q4?
During 2017 Q4 David Abrams has bought 7 securities out of which top 5 purchases (by % change to portfolio) were (TWX) Time Warner Inc (new buy), (ORLY) OReilly Automotive Inc (added shares +3.42%), (PCG) PG&E Corp (new buy), (QCP) Quality Care Properties Inc (added shares +1.55%) and (ABG) Asbury Automotive Group Inc (added shares +8.51%).
What did David Abrams invest in during 2017 Q4?
David Abrams's top 5 holdings (by % of portfolio) were (WU) Western Union Co (13.83%), (TEVA-OLD) Teva Pharma Industries Ltd ADR (12.60%), (BEN) Franklin Resources Inc (11.59%), (AABA) Altaba Inc (9.21%) and (TWX) Time Warner Inc (9.18%).
In the 2017 Q4 report(s) the following changes have been made to the top investments: (TEVA-OLD) Teva Pharma Industries Ltd ADR (reduced shares -8.70%) and (TWX) Time Warner Inc (new buy).
Warning: SEC insider reports detected for Abrams Capital Management (real-time trades and ownership disclosures)
1 transaction as of 1 week ago
11 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PG&E Corp
|
new
|
$44.83
|
-70.79%($13.10)
|
4.91%
|
2017 Q4
|
~0.25 years
|
||||
|
|
Time Warner Inc
|
new
|
$91.47
|
|
9.18%
|
2017 Q4
|
~0.25 years
|
||||
|
|
Suburban Propane Partners LP
|
+120.91%
|
$24.22
|
-27.91%($17.46)
|
1.23%
|
2017 Q2
|
~0.75 years
|
||||
|
|
Keryx Biopharmaceuticals Inc
|
+69.94%
|
$4.65
|
|
1.52%
|
2015 Q3
|
~2.50 years
|
||||
|
|
Asbury Automotive Group Inc
|
+8.51%
|
$64.00
|
+221.08%($205.49)
|
2.34%
|
2017 Q3
|
~0.50 years
|
||||
|
|
OReilly Automotive Inc
|
+3.42%
|
$16.04
|
+459.49%($89.72)
|
7.15%
|
2017 Q3
|
~0.50 years
|
||||
|
|
Quality Care Properties Inc
|
+1.55%
|
$13.81
|
|
2.36%
|
2016 Q4
|
~1.25 years
|
||||
|
|
Teva Pharma Industries Ltd ADR
|
-8.70%
|
$18.95
|
|
12.60%
|
2017 Q3
|
~0.50 years
|
||||
|
|
Digitalbridge Group Inc
|
-14.10%
|
$45.64
|
|
1.88%
|
2017 Q1
|
~1.00 year
|
||||
|
|
Wells Fargo & Company
|
-14.32%
|
$60.67
|
+41.45%($85.82)
|
5.85%
|
2013 Q4
|
~4.25 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".